​

ArriVent BioPharma Ownership | Who Owns ArriVent BioPharma?

OverviewForecastFinancialsChart

ArriVent BioPharma Ownership Summary

ArriVent BioPharma is owned by 84.77% institutional investors, 9.72% insiders, and 5.52% retail investors. Parallel advisors is the largest institutional shareholder, holding 0% of AVBP shares.

AVBP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockArriVent BioPharma84.77%9.72%5.52%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Parallel advisors---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Parallel advisors---

Top Buyers

HolderShares% AssetsChange
Parallel advisors---3.00

Top Sellers

HolderShares% AssetsChange
Parallel advisors---3.00

Sold Out

HolderChange
Parallel advisors-3.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20248120.90%28,465,9279.87%841.42%587.41%11266.67%
Sep 30, 20246726.42%25,908,14019.65%771.85%5458.82%3-57.14%
Jun 30, 202453-21,652,506-0.91%641.52%34-35.85%7-
Mar 31, 202453-21,851,944-65-53---

Recent Insider Transactions

DateNameRoleActivityValue
Jan 30, 2024HILLHOUSE INVESTMENT MANAGEMENT, LTD.-Buy$10.00M
Jan 30, 2024ORBIMED ADVISORS LLC Buy$4.00M
Jan 30, 2024GORDON CARL L Buy$4.00M
Jan 30, 2024HEALY JAMES-Buy$8.00M

Insider Transactions Trends

DateBuySell
2024 Q11-

AVBP Ownership FAQ

Who Owns ArriVent BioPharma?

ArriVent BioPharma shareholders are primarily institutional investors at 84.77%, followed by 9.72% insiders and 5.51% retail investors. The average institutional ownership in ArriVent BioPharma's industry, Biotech Stocks , is 68.48%, which ArriVent BioPharma exceeds.

Does Blackrock own ArriVent BioPharma?

BlackRock is not among the top 10 institutional shareholders of ArriVent BioPharma.

Who is ArriVent BioPharma’s biggest shareholder by percentage of total assets invested?

Parallel advisors is ArriVent BioPharma’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 ArriVent BioPharma shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools